Publications by authors named "Pietro Bulian"

46Publications

Low-dose radiotherapy in diffuse large B-cell lymphoma.

Hematol Oncol 2017 Dec 25;35(4):472-479. Epub 2016 Oct 25.

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy.

View Article and Find Full Text PDF
December 2017

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.

Curr Cancer Drug Targets 2016 ;16(8):659-668

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Via Franco Gallini 2, Postal code 33081, Aviano (PN), Italy.

View Article and Find Full Text PDF
October 2017

Primary Non-Hodgkin's Lymphoma of the Vulva: A Case Report and Literature Review.

Medicine (Baltimore) 2016 Mar;95(10):e3041

From the Gynecological Oncology Unit (NC, EL, FS); Division of Pathology (LA, VC); Cellular Therapy and High-Dose Chemotherapy Unit (MR); and Clinical and Experimental Onco-Hematology Unit (PB); CRO Centro di Riferimento Oncologico-National Cancer Institute, Aviano, Italy.

View Article and Find Full Text PDF
March 2016

Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.

World J Hepatol 2016 Jan;8(2):107-16

Gabriele Pozzato, Francesca Zorat, Giulia Moratelli, Department of Medical and Surgical Sciences, University of Trieste, 34100 Trieste, Italy.

View Article and Find Full Text PDF
January 2016

Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender.

Oncotarget 2015 Oct;6(31):31889-900

Division of Experimental Oncology 2, Department of Translational Research, CRO-IRCCS, Aviano, Pordenone, Italy.

View Article and Find Full Text PDF
October 2015

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

J Clin Oncol 2014 Mar 10;32(9):897-904. Epub 2014 Feb 10.

Pietro Bulian, Antonella Zucchetto, and Valter Gattei, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico, Aviano; Lilla Cro and Luca Baldini, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico and Università degli Studi, Milan; Gianluca Gaidano and Davide Rossi, Amedeo Avogadro University of Eastern Piedmont, Novara; Giovanni Del Poeta, Tor Vergata University, S. Eugenio Hospital, Rome, Italy; Tait D. Shanafelt, Mayo Research Center, Rochester, NY; Chris Fegan and Chris Pepper, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom; Holger Nückel, University of Duisburg-Essen, Essen, Germany; and Antonina V. Kurtova, Alessandra Ferrajoli, and Jan A. Burger, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
March 2014

Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.

Angiogenesis 2013 Apr 4;16(2):309-27. Epub 2012 Nov 4.

S.O.C. for Experimental Oncology 2, The National Cancer Institute Aviano, CRO-IRCCS, Via Pedemontana Occidentale 12, 33081, Aviano, PN, Italy.

View Article and Find Full Text PDF
April 2013

Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.

Immunol Lett 2011 Jan 13;134(2):137-44. Epub 2010 Oct 13.

Clinical and Experimental Hematology Research Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Via Franco Gallini 2, Aviano (PN), Italy.

View Article and Find Full Text PDF
January 2011

How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia.

Hematol Oncol 2009 Dec;27(4):186-9

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy.

View Article and Find Full Text PDF
December 2009

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.

Haematologica 2008 Oct 18;93(10):1575-9. Epub 2008 Jul 18.

Division of Hematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, via Solaroli 17, 28100 Novara, Italy.

View Article and Find Full Text PDF
October 2008

CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target.

Future Oncol 2008 Jun;4(3):355-8

Clinical & Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy.

View Article and Find Full Text PDF
June 2008

The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia.

Am J Clin Pathol 2004 Apr;121(4):489-95

Clinical Pathology Laboratory, Geriatric Hospital, Department of Laboratory Medicine, Padua, Italy.

View Article and Find Full Text PDF
April 2004